Koagulopatie asociovaná s infekcí covid-19 a riziko tromboembolismu – známe jejich vzájemnou souvislost a následné řešení?
|Title in English
|Coagulopathy associated with COVID-19 infection and risk of thromboembolism – do we know their relationship and subsequent solution?
|Year of publication
|Article in Periodical
|Magazine / Source
|Geriatrie a gerontologie
|MU Faculty or unit
|COVID-19; coagulopathy; thrombosis; risk factors; treatment; prophylaxis; cytokines
|At the end of 2019, a new coronavirus SARS-CoV-2 was identified, which caused a global pandemic. This acute infectious disease is associated with coagulopathy, which leads to a hypercoagulable state in patients. Coagulopathy in this disease is complex in feature and involves a number of different factors. Patients result in a high risk of venous as well as arterial thrombosis. This finding leads to the inclusion of measures in hospitalized and outpatient patients to reduce the proportion of thromboembolism in COVID-19 infection.